CURE develops a tool for the early detection of risks in supply chains
Since 2020, CURE Intelligence ( www.cure-intelligence.com) has been developing a tool for the early detection of risks in supply chains under the product name „CURE Supply Chain Radar“. Due to its great market potential, the company is being transformed into its own brand: scrioo („Supply Chain Resilience Instruments for Optimal Operations“).
Around a year before the German Bundestag passed the Supply Chain Due Diligence Act (LkSG) in 2021, CURE Intelligence began developing a flexible infrastructure for data-driven risk assessment and management in connection with ESG violations – the Supply Chain Radar.
Based on the very positive feedback from customers, CURE Intelligence has decided to further develop the solution. To this end, the Luxembourg Institute of Science and Technology (LIST; www.LIST.lu) has become a renowned partner. In addition, further development is being subsidised by the Luxembourg Ministry of the Economy. The company aims to develop a powerful, AI-driven platform for the reliable optimisation of risks in the supply chain, taking into account a wide variety of risk types such as delivery delays, delivery failures and financial risks. The aim is to provide companies with a comprehensive set of tools with which they can navigate safely through the new era of economic and political uncertainty.
The business potential is driven by push and pull factors: both politicians and companies themselves are looking for solutions to make their supply chains sustainable, responsible and resilient. In order to tap into this potential more quickly, CURE Intelligence has now incorporated the solution into its own new brand with ’scrioo‘.
Marco Feiten, Managing Director of CURE Intelligence, comments: „CURE Intelligence has stood for excellent services in the fields of media intelligence and online marketing since 2009. With our solutions in the area of supply chain resilience, we have broken new ground – and not just thematically. scrioo has to be marketed as a platform solution in a completely different way to services. We also solve problems for other or new target groups. It is therefore the right step to establish our own brand – separate from CURE. I am personally very much looking forward to dedicating myself primarily to scrioo’s success from 2024 and convincing new customers and partners of the platform.“
Dr Joscha Krause, Head of Analytics & Insights at CURE Intelligence, adds: „The combination of services and big data analytics has been deeply rooted in the company’s DNA since its founding days. Over the past four years, we have built up a very strong team of data scientists and data engineers who transform this basis into innovative AI-driven solutions. Against this backdrop, scrioo combines all the strengths of CURE into a powerful tool that is consistently geared towards the needs of customers and is continuously developed over time.“
Our mission is to sustainably improve the way companies manage their supply chain risks. By combining cutting-edge technology, such as generative AI and big real-time data, we strive to promote transparency, efficiency and sustainability along the entire supply chain. We are passionate about giving our clients the tools they need to overcome challenges, seize opportunities, and build a responsible, future-focused supply chain.
Kontakt
scrioo – a trademark of CURE S.A.
Samantha Kohll
Schaffmill 3
6778 Grevenmacher
00 49 651 56152334
https://www.scrioo.com/
Die Bildrechte liegen bei dem Verfasser der Mitteilung.
